FR5953M - - Google Patents

Info

Publication number
FR5953M
FR5953M FR82837A FR82837A FR5953M FR 5953 M FR5953 M FR 5953M FR 82837 A FR82837 A FR 82837A FR 82837 A FR82837 A FR 82837A FR 5953 M FR5953 M FR 5953M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR82837A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR5953M publication Critical patent/FR5953M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR82837A 1966-05-31 1966-11-08 Expired FR5953M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6607516A NL6607516A (fr) 1966-05-31 1966-05-31

Publications (1)

Publication Number Publication Date
FR5953M true FR5953M (fr) 1968-04-16

Family

ID=19796753

Family Applications (1)

Application Number Title Priority Date Filing Date
FR82837A Expired FR5953M (fr) 1966-05-31 1966-11-08

Country Status (22)

Country Link
US (1) US3557280A (fr)
JP (1) JPS5010373B1 (fr)
AT (1) AT272522B (fr)
BE (1) BE699091A (fr)
CH (1) CH490087A (fr)
CS (1) CS151454B2 (fr)
DE (1) DE1617576C3 (fr)
DK (1) DK117587B (fr)
ES (1) ES340956A1 (fr)
FI (1) FI43622B (fr)
FR (1) FR5953M (fr)
GB (1) GB1131007A (fr)
GR (1) GR33861B (fr)
IL (1) IL28009A (fr)
IT (1) IT1140250B (fr)
LU (1) LU53788A1 (fr)
MY (1) MY7100015A (fr)
NL (1) NL6607516A (fr)
NO (1) NO126298B (fr)
SE (1) SE354417B (fr)
SU (1) SU510986A3 (fr)
YU (1) YU31326B (fr)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5418330B2 (fr) * 1973-03-16 1979-07-06
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
US3929989A (en) * 1974-06-14 1975-12-30 Wendt Lab Inc Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
GB1592053A (en) * 1976-12-16 1981-07-01 Norbrook Lab Ltd Oxytetracycline compositions
US4213963A (en) * 1978-12-14 1980-07-22 Janssen Pharmaceutica N.V. Fluspirilene-containing compositions
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (fr) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Solution injectable à base d'oxytetracycline ou doxycycline contenant de la PVP et de la N-methylpyrrolidone et/ou de la 2-pyrrolidone
US6383515B2 (en) 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
CA2672722C (fr) 1999-09-14 2013-11-05 Trustees Of Tufts College Techniques de preparation de tetracyclines substituees avec des solutions chimiques a base de metal de transition
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
US6833365B2 (en) 2000-01-24 2004-12-21 Trustees Of Tufts College Tetracycline compounds for treatment of Cryptosporidium parvum related disorders
CN1430600A (zh) * 2000-03-31 2003-07-16 塔夫茨大学信托人 7－和9－氨基甲酸酯、脲、硫脲、硫代氨基甲酸酯,和杂芳基－氨基取代的四环素化合物
DE60102815D1 (de) 2000-05-15 2004-05-19 Paratek Pharm Innc 7-substituierte kondensierte ring-tetrazyclin- verbindungen
AU2001268475A1 (en) * 2000-06-16 2002-01-02 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
ATE504562T1 (de) 2000-07-07 2011-04-15 Tufts College 7-, 8- und 9-substitutierte tetracyclinverbindungen
EA200300136A1 (ru) 2000-07-07 2003-06-26 Трастис Оф Тафтс Коллидж 13-замещенное соединение метациклина (варианты) и способ его получения (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния млекопитающего
KR100674047B1 (ko) 2000-07-07 2007-01-25 트러스티즈 오브 터프츠 칼리지 9-치환된 미노사이클린 화합물
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
US6818635B2 (en) * 2000-07-07 2004-11-16 Paratek Pharmaceuticals, Inc. 7-substituted tetracycline compounds
WO2002072506A2 (fr) * 2001-03-13 2002-09-19 Paratek Pharmaceuticals, Inc. Composes de 7-pyrollyl tetracycline et procedes d'utilisation associes
IL157860A0 (en) 2001-03-13 2004-03-28 Paratek Pharm Innc 7,9-substituted tetracycline compounds
JP2004530661A (ja) * 2001-03-14 2004-10-07 パラテック ファーマシューティカルズ インコーポレイテッド 抗真菌剤としての置換テトラサイクリン化合物
JP2005504722A (ja) 2001-03-14 2005-02-17 パラテック ファーマシューティカルズ インコーポレイテッド 相乗的抗真菌薬剤としての置換テトラサイクリン化合物
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
ATE455092T1 (de) 2001-04-24 2010-01-15 Paratek Pharm Innc Substituierte tetracyclin-verbindungen zur behandlung von malaria
EP2311797A1 (fr) * 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. Composés de tétracycline 4-dedimethylamino
CN102531948A (zh) 2002-03-08 2012-07-04 帕拉特克药品公司 氨基-甲基取代的四环素类化合物
WO2003079984A2 (fr) 2002-03-21 2003-10-02 Paratek Pharmaceuticals, Inc. Composes de tetracycline substituee
EP1534300A4 (fr) 2002-07-12 2008-04-23 Paratek Pharm Innc Composes de tetracycline substituee en 3, 10, et 12a
JP2006503898A (ja) 2002-10-24 2006-02-02 パラテック ファーマシューティカルズ， インク． マラリア治療のための置換テトラサイクリン化合物
EP1605916A4 (fr) * 2003-02-12 2012-02-22 R & P Korea Co Ltd Systeme de solvants de medicament a peine soluble a taux d'elution ameliore
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
JP4738333B2 (ja) 2003-07-09 2011-08-03 パラテック ファーマシューティカルズ インコーポレイテッド ９−アミノメチルテトラサイクリン化合物のプロドラッグ
EP2298323A3 (fr) 2003-07-09 2011-05-11 Paratek Pharmaceuticals, Inc. Composés de tétracycline substitués
EP1716101A1 (fr) * 2004-01-15 2006-11-02 Paratek Pharmaceuticals, Inc. Derives a cycle aromatique a provenant de composes de tetracycline
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
EP2301916A3 (fr) 2004-10-25 2011-09-28 Paratek Pharmaceuticals, Inc. 4-aminotétracyclines et procédés d'utilisation associés
EP2284150A3 (fr) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Composés de tétracycline substituée
EP1848685A1 (fr) 2005-02-04 2007-10-31 Paratek Pharmaceuticals, Inc. Derives 11a, 12 de composes de tetracycline
DE102005012595A1 (de) * 2005-03-18 2006-09-21 Lanxess Deutschland Gmbh Herstellung von Tri(chlorpropyl)phosphat
JP2009502809A (ja) * 2005-07-21 2009-01-29 パラテック ファーマシューティカルズ インコーポレイテッド １０−置換テトラサイクリンおよびその使用方法
JP2009508951A (ja) * 2005-09-19 2009-03-05 アルベマール・コーポレーシヨン カリウムイブプロフェンの極めて濃厚な注入可能な水溶液、その製造法および使用
EP1991236A2 (fr) * 2006-01-24 2008-11-19 Paratek Pharmaceuticals, Inc. Procede permettant d'accroitre la biodisponibilite orale de tetracyclines
CA2649221A1 (fr) * 2006-04-17 2007-10-25 Evgeny Tsiperman Isolement de derives de la tetracycline
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
PL2016045T3 (pl) * 2006-04-24 2015-04-30 Teva Pharma Krystaliczna postać tygecykliny i sposoby jej otrzymywania
JP2009543544A (ja) * 2006-05-15 2009-12-10 パラテック ファーマシューティカルズ インコーポレイテッド 置換されたテトラサイクリン化合物を用いて、遺伝子または遺伝子産物の発現を調節する方法
WO2008045507A2 (fr) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Composés de tétracycline substitués utilisés pour le traitement d'infections à bacillus anthracis
US8513223B2 (en) 2006-12-21 2013-08-20 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
KR101538175B1 (ko) 2006-12-21 2015-07-20 파라테크 파마슈티컬스, 인크. 박테리아, 바이러스 및 기생충 감염의 치료를 위한 테트라시클린 유도체
JP2010523684A (ja) * 2007-04-12 2010-07-15 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリン化合物を用いる、脊髄筋委縮症を治療するための方法
EP2144870A2 (fr) * 2007-04-27 2010-01-20 Paratek Pharmaceuticals, Inc. Procedes de synthese et de purification de composes d'aminoalkyltetracycline
EP2192111A3 (fr) 2007-07-06 2010-10-06 Paratek Pharmaceuticals, Inc. Procédés servant à synthétiser des composés de tétracycline substituée
EP2262754A4 (fr) 2008-03-05 2012-03-14 Paratek Pharm Innc Composés de minocycline et procédés d utilisation de ceux-ci
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
US20100022483A1 (en) * 2008-04-14 2010-01-28 Paratek Pharmaceuticals, Inc. Substituted Tetracycline Compounds
TW202332671A (zh) * 2008-05-23 2023-08-16 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629806B2 (en) * 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
EP2341771A4 (fr) * 2008-09-19 2012-08-15 Paratek Pharm Innc Composés de tétracycline utilisés dans le traitement de la polyarthrite rhumatoïde et méthodes thérapeutiques associées
DE202010018378U1 (de) 2009-04-10 2016-04-07 Tufts Medical Center, Inc. PAR-1-Aktivierung durch Metalloproteinase-1 (MMP-1)
EP3574908B8 (fr) 2011-05-12 2024-09-11 Almirall LLC Composition pharmaceutique pour adminstration par voie orale comprenant des sels cristallins d'amide de l'acide (4s,4as,5ar,12as)-4-diméthylamino- 3,10,12,12a-tétrahydroxy-7-[(méthoxy(méthyl)amino)-méthyl]- 1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphtacène-2-carboxylique
MX2019005070A (es) 2016-11-01 2019-09-23 Paratek Pharm Innc Compuestos de 9-aminometil minociclina y su uso en el tratamiento de neumonía bacteriana adquirida en la comunidad (cabp).
CA3070663A1 (fr) 2017-07-21 2019-01-24 Almirall, Llc Traitement de lesions non inflammatoires

Also Published As

Publication number Publication date
YU31326B (en) 1973-04-30
SU510986A3 (ru) 1976-04-15
SE354417B (fr) 1973-03-12
CS151454B2 (fr) 1973-10-19
LU53788A1 (fr) 1967-07-31
BE699091A (fr) 1967-11-27
NL6607516A (fr) 1967-12-01
NO126298B (fr) 1973-01-22
GB1131007A (en) 1968-10-16
IT1140250B (it) 1986-09-24
DE1617576C3 (de) 1980-12-11
JPS5010373B1 (fr) 1975-04-21
AT272522B (de) 1969-07-10
DE1617576B2 (de) 1980-04-10
DE1617576A1 (de) 1972-04-27
DK117587B (da) 1970-05-11
CH490087A (de) 1970-05-15
IL28009A (en) 1970-08-19
FI43622B (fr) 1971-02-01
MY7100015A (en) 1971-12-31
GR33861B (el) 1968-02-09
US3557280A (en) 1971-01-19
ES340956A1 (es) 1968-06-16

Similar Documents

Publication Publication Date Title
FR5953M (fr)
AU5917865A (fr)
AU428063B2 (fr)
AU424443B2 (fr)
AU433222B2 (fr)
AU417216B2 (fr)
AU421822B2 (fr)
AU6703465A (fr)
AU5895065A (fr)
AU612166A (fr)
BE691497A (fr)
BE693706A (fr)
AU6852465A (fr)
BE692397A (fr)
BE692371A (fr)
BE692081A (fr)
BE693173A (fr)
AU92366A (fr)
BE691457A (fr)
BE689927A (fr)
BE688408A (fr)
BE284991A (fr)
BE475118A (fr)
BE693664A (fr)
AU855865A (fr)